GlobalRPh Renal Dosing Masterv6.6
Source-specific lookup | Version 6.6

Find the guidance.
Keep the qualifications.

Look for a clinical topic across locally stored sources. Every result opens the complete stored source and its drug-level cautions.

A pharmacokinetic observation is not a dosing instruction

The finding-type filter groups stored source categories, not evidence quality. Dose instructions, no-adjustment statements, qualitative cautions and PK-only observations stay separate. A source may discuss other issues beyond its primary category. Old cards are not reclassified; choose all types or the unclassified group when a narrow search misses useful text. Counts describe the full library, not just the current search.

Match the source's renal measure, not just the number

406 source summaries have a manually checked measure label; 1013 remain unclassified. Classification covers selected v4.2 through v5.9 summaries. Older and unresolved-method text remains available. Use the optional unclassified-source setting when narrowing by renal measure; other filters still apply. A narrow filter can omit relevant dosing guidance.

Measured urine-collection CrCl, estimated CrCl, BSA-indexed CrCl and indexed eGFR are not interchangeable simply because numbers look similar. A percentage-of-normal statement is not a numeric eGFR cutoff. This filter makes no calculation, conversion or recommendation.

Read renal-measure guidance

Source family and topic are not prescribing decisions

Qualified no-adjustment statements apply only to the source's stated scope. A pharmacokinetic observation is not automatically a dosing recommendation. "Not studied" is not "no adjustment." Read restrictions, interactions, monitoring and dialysis context even when searching only for a dose.

A label mirror and its original label are not independent corroboration. Source families identify storage provenance, not quality, currency or clinical approval. Professional material can include institutional policy, research or regulatory notices; read the actual source. Recent source summaries have manually assigned topic labels. Earlier summaries use their existing content categories; many remain unclassified. The optional topic-unclassified setting is off by default. It includes only unclassified candidates, not sources labeled solely for a different topic. Renal measure, family and text filters still apply. Labels describe selected stored content, not evidence quality, source agreement or independent clinical approval. A narrow filter can miss relevant material.

Separate label matches from material needing review

1 renal-measure label matches; 3 unclassified sources included for manual review.

Matching a measure label is not dosing eligibility. Unclassified sources may contain relevant guidance; they have not been asserted to use your selected estimate. Label matches appear first, not because they are clinically preferred. Topic, source-family and search filters still apply.

Show measure-label matches only

4 matching source entries. Showing 1-4; page 1 / 1.

Renal-measure label match; not clinical eligibility

Dose / interval guidanceProfessional / research / regulatoryDose / interval guidanceMonitoring / toxicity / cautions

Ertapenem (Invanz)

UCSF adult ertapenem renal and dialysis guidance

Professional / research / regulatory | Manually labeled selected summary

Product / population: UCSF adult institutional ertapenem: non-dialysis, intermittent HD and continuous HD. Not universal CRRT guidance.

Renal measure: CrCl mL/min; modality-specific institutional schedules.

Measure label: CrCl in mL/min. Read the exact source wording above.

Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.

Source dates and additional notes

Source revision: Source revision date not established in selected retrieval.
Retrieved: 2026-09-07

Drug-level caution

The source uses indexed renal thresholds but prints an unindexed Cockcroft-Gault formula; preserve the distinction rather than silently treating the units as equivalent.

2 documented source differences / product cautions

Unclassified renal measure; manual review required

Not classified by finding typeProfessional / research / regulatoryUnclassified / original material

Ertapenem (Invanz)

UCSF - ertapenem

Professional / research / regulatory | Existing source category; topic coverage may be incomplete

Product / population: Adults; source-specific institutional guidance. Match route, indication and renal replacement modality.

Renal measure: CrCl in mL/min where specified; no equation inferred.

Measure label: Measure not yet classified. Read the exact source wording above.

Locally included source-specific summary. Regimen differences are not automatically resolved.

Source dates and additional notes

Source revision: Revision date not stated in the reviewed page.
Retrieved: 2026-09-05

The exact CrCl 30 boundary is incomplete in the website table. Apply an exact current label or an adjudicated institutional rule, not an inferred boundary.

Drug-level caution

The source uses indexed renal thresholds but prints an unindexed Cockcroft-Gault formula; preserve the distinction rather than silently treating the units as equivalent.

2 documented source differences / product cautions

Unclassified renal measure; manual review required

Not classified by finding typeProfessional / research / regulatoryUnclassified / original material

Ertapenem (Invanz)

Sunnybrook - ertapenem renal and replacement-therapy schedule

Professional / research / regulatory | Existing source category; topic coverage may be incomplete

Product / population: Adult institutional ertapenem guidance.

Renal measure: CrCl in mL/min; HD, PD, CRRT and SLED distinguished.

Measure label: Measure not yet classified. Read the exact source wording above.

Locally included source-specific summary. Regimen differences are not automatically resolved.

Source dates and additional notes

Source revision: Revision date not stated in the reviewed page.
Retrieved: 2026-09-05

Drug-level caution

The source uses indexed renal thresholds but prints an unindexed Cockcroft-Gault formula; preserve the distinction rather than silently treating the units as equivalent.

2 documented source differences / product cautions

Unclassified renal measure; manual review required

Not classified by finding typePreserved GlobalRPh originalsUnclassified / original material

Ertapenem (Invanz)

Preserved original GlobalRPh material

Preserved original source | Original source not assigned new topic labels

Product / population: Original source text retained without a new current-label review.

Renal measure: Read the measure stated in the original source.

Measure label: Measure not yet classified. Read the exact source wording above.

Preserved original material; current clinical validation not established.

Source dates and additional notes

Source revision: Not established
Retrieved: 2026-09-05

Drug-level caution

The source uses indexed renal thresholds but prints an unindexed Cockcroft-Gault formula; preserve the distinction rather than silently treating the units as equivalent.

2 documented source differences / product cautions

Compare before choosing

Keep each source's dose, interval, renal measurement, indication, route and dialysis assumptions together. Do not construct a hybrid regimen from different sources.